002737.SZ
002737.SZ
CNE100001WT7
SFPM
Loading chart...

Company Profile

Sunflower Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of Chinese medicines in China and internationally. It offers traditional Chinese medicines, chemical drugs, biological drugs, and health and wellness products, as well as adult and children's medicines for various therapeutic areas, including pediatrics, gynecology, digestive system, respiratory and cold ailments, rheumatism and bone disease, cardiovascular and cerebrovascular diseases, and general health. The company is also involved in leasing and business services; scientific research and technical services; and wholesale and retail trade. It sells its products under the Sunflower and Little Sunflower brand names. The company was founded in 2005 and is headquartered in Harbin, China.

Related stocks

600195.SS
600195.SS • China
CHINA ANIMAL HUSBANDRY INDUSTRY
6.73 CNY
1.03B USD 1Y -6%
002275.SZ
002275.SZ • China
GLSJ
12.35 CNY
1.09B USD 1Y -16%
600129.SS
600129.SS • China
CHONGQING TAIJI IND
13.97 CNY
1.15B USD 1Y -36.3%
002349.SZ
002349.SZ • China
JINGHUA PHARM
9.24 CNY
1.15B USD 1Y +28.3%
000650.SZ
000650.SZ • China
RENHE PHARMACY CO LTD
5.29 CNY
1.11B USD 1Y -12.9%
600252.SS
600252.SS • China
GUANGXI WUZHOU ZHONGHENG GROUP
2.25 CNY
1.07B USD 1Y -17.6%
600789.SS
600789.SS • China
SHANDONG LUKANG PHARMACEUTICAL
8.28 CNY
1.29B USD 1Y -15.3%
300702.SZ
300702.SZ • China
TIANYU PHARMA
22.18 CNY
1.15B USD 1Y -13.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
36.1% p.a.
Max Drawdown (5Y)
-63.6%
Sharpe Ratio (5Y)
-0.18
Beta Factor
0.23
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Unprofitable business model: The company is currently generating net losses.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (36.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -63.6% in the extended horizon.
ende